MedPath

The brain activity and motor performance during obstacle-crossing gait and effects of motor and cognition complex training - Study of Parkinson's disease with or without mild cognitive impairment (Part II)

Phase 2
Recruiting
Conditions
Parkinson&#039
s disease with or without mild cognitive impairment
s disease
Mild cognitive impairment
Registration Number
TCTR20210420003
Lead Sponsor
ational Yang Ming Chiao Tung University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Parkinson's disease without cognitive impairment: 1) Diagnosed with idiopathic PD by a neurologist, 2) Hoehn and Yahr stage I to III, 3) Receive regular medication for treating Parkinson's disease, e.g., Levodopa, 4) >3 months of stable anti-Parkinson's medication, 5) Walk 1 min independently without assistive device, 6) Correctly respond to visual and auditory information, 7) Mini-mental state examination (MMSE) >=24, and 8) 20-80 years old Parkinson's disease with cognitive impairment: same as above, as well as 9) Montreal Cognitive Assessment (MoCA) <26

Exclusion Criteria

All participants: 1) unstable health condition, and 2) any orthopedic, neurological, or psychological disease affecting participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Brain activity assess after enrollment functional near-infrared spectroscope (fNIRS),Obstacle-crossing performance assess after enrollment GaitRite system,Obstacle-crossing gait assess after enrollment Gait up
Secondary Outcome Measures
NameTimeMethod
Global cognitive function assess after enrollment Montreal Cognitive Assessment,Executive function assess after enrollment Verbal Fluency Test,Attention assess after enrollment Digit Span Test,Visuospatial assess after enrollment Rey Osterrieth Complex Figure test,Usual walking performance assess after enrollment Gait up,Balance assess after enrollment Timed up and go,Motor symptom assess after enrollment Unified Parkinson&#039;s Disease Rating Scale-Part III,Falls risk assess after enrollment Falls Efficacy Scale International,Quality of life assess after enrollment Parkinson&#039;s disease questionnaire-39 item
© Copyright 2025. All Rights Reserved by MedPath